COVID-19 Associated Coagulopathy in Egypt

Status Completed

Clinical Trial Summary

Coagulopathy is one of the most significant prognostic factors in patients with COVID-19 and is associated with increased mortality and admission to critical care. Most commonly observed coagulopathy in patients hospitalized with COVID-19 (COVID-19-associated coagulopathy) is characterized by increased D-dimer and fibrinogen levels. 71% of patients who did not survive hospitalization reported to have developed disseminated intravascular coagulation (DIC) compared to 0.6% of survivors.

Clinical Trial Description

studying the detailed coagulation screen and second line coagulation parameters including both thrombophilia screen and other acute phase coagulation factors. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04507230
Study type	Observational
Source	Assiut University
Contact
Status	Completed
Phase
Start date	August 7, 2020
Completion date	October 31, 2020

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT01912547` - Thromboelastography During Surgery for Malignant Pleural Mesothelioma	Phase 0
Completed	`NCT03674684` - ROTEM Assessment of Modern Crystalloid, Hydroxyethyl Starch and Gelatin Effect on Coagulation
Recruiting	`NCT05874843` - Validation of Point-of-care Thromboelastography (TEG 6s) in Pediatric Patients	N/A
Withdrawn	`NCT04705701` - Comparing Post Cardiac Surgery Outcomes in ESRD Patient's With Early Dialysis Versus Standard Care	N/A
Not yet recruiting	`NCT04515420` - The Influence of Noradrenaline on Coagulation and Fibrinolysis in Severe Isolated Brain Injury
Completed	`NCT01598831` - Phase 3 Safety and Efficacy Study of ART-123 in Subjects With Severe Sepsis and Coagulopathy	Phase 3
Completed	`NCT04580563` - Study Assessing Efficacy of Plasmatherapy in Septic Shock-induced Coagulopathy: Feasibility Study	N/A
Withdrawn	`NCT04274699` - Clinical Evaluation of the Hemosonics Quantra® Coagulation Monitor in Liver and Multivisceral Transplantation
Terminated	`NCT02540434` - Trial of RiaSTAP Versus Cryoprecipitate to Lower Operative Transfusions	N/A
Completed	`NCT02203968` - Fibrinogen in the Initial Resuscitation of Severe Trauma (FiiRST)	Phase 1/Phase 2
Unknown status	`NCT01854476` - Safety and Efficacy Study Comparing Pad-gauze With Anti-fibrinolytic Agent Hemostopan™) to a Regular Pad-gauze	Phase 2/Phase 3
Completed	`NCT00816127` - Prevention of Bleeding in Patient With Cirrhosis Undergoing Dental Extraction	N/A
Active, not recruiting	`NCT02926274` - Transfusion Using Stored Whole Blood	N/A
Completed	`NCT05295693` - Quantra vs TEG for Congenital Cardiac Surgery - a Pilot Validation Study
Not yet recruiting	`NCT04582188` - The Early Coagulopathy for the Prognosis in Sepsis
Recruiting	`NCT04528888` - Steroids and Unfractionated Heparin in Critically Ill Patients With Pneumonia From COVID-19 Infection	Phase 3
Recruiting	`NCT05449834` - Fibrinogen Early In Severe Trauma StudY II	Phase 3
Withdrawn	`NCT04435015` - The Utility of Camostat Mesylate in Patients With COVID-19 Associated Coagulopathy (CAC) and Cardiovascular Complications	Phase 1/Phase 2
Not yet recruiting	`NCT04115722` - Coagulation Parameters in IBD Patients
Completed	`NCT01228058` - A Prospective Evaluation of Thromboelastography for Identifying Coagulopathy in Severely Injured Patients	N/A